Molecular basis of tobacco-induced bacterial biofilms: An in vitro study

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 5, 2012, Pages 876-884

  Antunes, Marcelo B ^a   Chi, John J ^a   Liu, Zhi ^b   Goldstein Daruech, Natalia ^c   Palmer, James N ^a   Zhu, Jun ^b   Cohen, Noam A ^a,d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biofilm; Chronic Rhinosinusitis; Oxidative Stress; Quorum Sensing; Tobacco; Virulence Factor

Indexed keywords

ALGC PROTEIN; BACTERIAL PROTEIN; CRYSTAL VIOLET; FLGK PROTEIN; HYDROGEN PEROXIDE; LASB PROTEIN; LASI PROTEIN; PILF PROTEIN; RHLA PROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM; BACTERIUM CULTURE; BIOFILM; BIOMASS; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; OPTICAL DENSITY; OXIDATIVE STRESS; PLASMID; PSEUDOMONAS AERUGINOSA; REPORTER GENE; STAINING; TOBACCO; UNITED STATES; UNIVERSITY; GENETICS; PASSIVE SMOKING; PHYSIOLOGY;

BIOFILMS; GENE EXPRESSION; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; TOBACCO SMOKE POLLUTION;

EID: 84872045214     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812447263     Document Type: Article

References (80)

1. Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol. 2011;120:423-427.
2. Bhattacharyya N. Ambulatory sinus and nasal surgery in the United States: Demographics and perioperative outcomes. Laryngoscope. 2010;120:635-638.
3. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg. 2007;137:S1-S31.
4. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104-109.
5. Prince AA, Steiger JD, Khalid AN, et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol. 2008;22:239-245.
6. Psaltis AJ, Weitzel EK, Ha KR, Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol. 2008;22:1-6.
7. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg. 2006;134:991-996.
8. Palmer JN. Bacterial biofilms: Do they play a role in chronic sinusitis? Otolaryngol Clin North Am. 2005;38:1193-1201.
9. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15:167-193.
10. Mackay J, Eriksen M. The Tobacco Atlas. Geneva, Switzerland: World Health Organization; 2002.
11. US Department of Health. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: US Department of Health, US Public Health Service; 1964.
12. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. Arch Otolaryngol Head Neck Surg. 2000;126:940-946.
13. Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003;113:1199-1205.
14. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope. 1992;102:1-18.
15. Ramadan HH, Hinerman RA. Smoke exposure and outcome of endoscopic sinus surgery in children. Otolaryngol Head Neck Surg. 2002;127:546-548.
16. Smith TL, Mendolia-Loffredo S, Loehrl TA, Sparapani R, Laud PW, Nattinger AB. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2005;115:2199-2205.
17. Briggs RD, Wright ST, Cordes S, Calhoun KH. Smoking in chronic rhinosinusitis: A predictor of poor long-term outcome after endoscopic sinus surgery. Laryngoscope. 2004;114: 126-128.
18. Goldstein-Daruech N, Cope EK, Zhao KQ, et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS One. 2011;6:e15700.
19. Pseudomonas Genome Database. www.pseudomonas.com
20. Hoang TT, Kutchma AJ, Becher A, Schweizer HP. Integration-proficient plasmids for Pseudomonas aeruginosa: Site-specific integration and use for engineering of reporter and expression strains. Plasmid. 2000;43:59-72.
21. Savitski AN, Mesaros C, Blair IA, Cohen NA, Kreindler JL. Secondhand smoke inhibits both Cl-and K1 conductances in normal human bronchial epithelial cells. Respir Res. 2009; 27(10):120.
22. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-2216.
23. Kreindler JL, Jackson AD, Kemp PA, Bridges RJ, Danahay H. Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract. Am J Physiol Lung Cell Mol Physiol. 2005;288:L894-L902.
24. Cohen NA, Zhang S, Sharp DB, et al. Cigarette smoke condensate inhibits transepithelial chloride transport and ciliary beat frequency. Laryngoscope. 2009;119:2269-2274.
25. Fullmer SC, Preshaw PM, Heasman PA, Kumar PS. Smoking cessation alters subgingival microbial recolonization. J Dent Res. 2009;88:524-528.
26. Brook I, Gober AE. Recovery of potential pathogens in the nasopharynx of healthy and otitis media-prone children and their smoking and nonsmoking parents. Ann Otol Rhinol Laryngol. 2008;117:727-730.
27. Bagaitkar J, Williams LR, Renaud DE, et al. Tobacco-induced alterations to Porphyromonas gingivalis-host interactions. Environ Microbiol. 2009;11:1242-1253.
28. McMaster SK, Paul-Clark MJ, Walters M, et al. Cigarette smoke inhibits macrophage sensing of gram-negative bacteria and lipopolysaccharide: Relative roles of nicotine and oxidant stress. Br J Pharmacol. 2008;153:536-543.
29. Schlag S, Nerz C, Birkenstock TA, Altenberend F, Gotz F. Inhibition of staphylococcal biofilm formation by nitrite. J Bacteriol. 2007;189:7911-7919.
30. Miranda JE, Sotomayor CE, Albesa I, Paraje MG. Oxidative and nitrosative stress in Staphylococcus aureus biofilm. FEMS Microbiol Lett. 2011;315:23-29.
31. Hoopman TC, Liu W, Joslin S, Pybus C, Brautigam CA, Hansen EJ. Identification of gene products involved in the oxidative stress response of Moraxella catarrhalis. Infect Immun. 2011;79:745-755.
32. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;30:295-304.
33. Craig L, Pique ME, Tainer JA. Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol. 2004;2:363-378.
34. Chiang P, Burrows LL. Biofilm formation by hyperpiliated mutants of Pseudomonas aeruginosa. J Bacteriol. 2003;185: 2374-2378.
35. Levine MM, Nataro JP, Karch H, et al. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis. 1985;152:550-559.
36. Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, Levine MM. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med. 1988;168:1487-1492.
37. Tacket CO, Taylor RK, Losonsky G, et al. Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun. 1998;66:692-695.
38. Bieber D, Ramer SW, Wu CY, et al. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science. 1998;280:2114-2118.
39. Koo J, Tammam S, Ku SY, Sampaleanu LM, Burrows LL, Howell PL. PilF is an outer membrane lipoprotein required for multimerization and localization of the Pseudomonas aeruginosa type IV pilus secretin. J Bacteriol. 2008;190:6961-6969.
40. Watson AA, Alm RA, Mattick JS. Identification of a gene, pilF, required for type 4 fimbrial biogenesis and twitching motility in Pseudomonas aeruginosa. Gene. 1996;180:49-56.
41. Touhami A, Jericho MH, Boyd JM, Beveridge TJ. Nanoscale characterization and determination of adhesion forces of Pseudomonas aeruginosa pili by using atomic force microscopy. J Bacteriol. 2006;188:370-377.
42. Maier B. Using laser tweezers to measure twitching motility in Neisseria. Curr Opin Microbiol. 2005;8:344-349.
43. Hentzer M, Wu H, Andersen JB, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 2003;22:3803-3815.
44. Schuster M, Lohstroh CP, Ogi T, Greenberg EP. Identification, timing and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: A transcriptome analysis. J Bacteriol. 2003;185:2066-2079.
45. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorumsensing regulons: Effects of growth phase and environment. J Bacteriol. 2003;185:2080-2095.
46. Latifi A, Foglino M, Tanaka K, Williams P, Lazdunski A. A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators lasR and rhIR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol Microbiol. 1996;21:1137-1146.
47. Pesci EC, Pearson JP, Seed PC, Iglewski BH. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol. 1997;179:3127-3132.
48. Medina G, Juarez K, Diaz R, Soberon-Chavez G. Transcriptional regulation of Pseudomonas aeruginosa rhlR, encoding a quorum-sensing regulatory protein. Microbiology. 2003;149:3073-3081.
49. Dekimpe V, Deziel E. Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: The transcriptional regulator rhlR regulates lasR-specific factors. Microbiology. 2009;155: 712-723.
50. Duan K, Surette MG. Environmental regulation of Pseudomonas aeruginosa PAO1 las and rhl quorum-sensing systems. J Bacteriol. 2007;189:4827-4836.
51. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: The LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol. 1994;176:269-275.
52. Bjarnsholt T, Givskov M. The role of quorum sensing in the pathogenicity of the cunning aggressor Pseudomonas aeruginosa. Anal Bioanal Chem. 2007;387:409-414.
53. Gambello MJ, Iglewski BH. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol. 1991;173:3000-3009.
54. Brint JM, Ohman DE. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of rhlR-rhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J Bacteriol. 1995; 177:7155-7163.
55. Tamura Y, Suzuki S, Kijima M, Takahashi T, Nakamura M. Effect of proteolytic enzyme on experimental infection of mice with Pseudomonas aeruginosa. J Vet Med Sci. 1992;54: 597-599.
56. Kamath S, Kapatral V, Chakrabarty AM. Cellular function of elastase in Pseudomonas aeruginosa: Role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol Microbiol. 1998;30:933-941.
57. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gammamediated macrophage killing. J Immunol. 2005;175:7512-7518.
58. Mathee K, Ciofu O, Sternberg C, Lindum P. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung. Microbiology. 1999;145:1349-1357.
59. Pedersen SS, Kharazmi A, Espersen F, Hoiby N. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun. 1990;58:3363-3368.
60. Cathcart GR, Quinn D, Greer B, et al. Novel inhibitors of the Pseudomonas aeruginosa virulence factor lasB: A potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob Agents Chemother. 2011;55:2670-2678.
61. Beal R, Betts WB. Role of rhamnolipid biosurfactants in the uptake and mineralization of hexadecane in Pseudomonas aeruginosa. J Appl Microbiol. 2000;89:158-168.
62. Al-Tahhan RA, Sandrin TR, Bodour AA, Maier RM. Rhamnolipid-induced removal of lipopolysaccharide from Pseudomonas aeruginosa: Effect on cell surface properties and interaction with hydrophobic substrates. Appl Environ Microbiol. 2000;66:3262-3268.
63. Stutts MJ, Schwab JH, Chen MG, Knowles MR, Boucher RC. Effects of Pseudomonas aeruginosa on bronchial epithelial ion transport. Am Rev Respir Dis. 1986;134:17-21.
64. Abalos A, Pinazo A, Infante MR, Casals M, Garcia F, Manresa A. Physicochemical and antimicrobial properties of new rhamnolipids produced by Pseudomonas aeruginosa AT10 from soybean oil refinery wastes. Langmuir. 2001;17:1367-1371.
65. Benincasa M, Abalos A, Oliveira I, Manresa A. Chemical structure, surface properties and biological activities of the biosurfactant produced by Pseudomonas aeruginosa LBI from soapstock. Int J Gen Mol Microbiol. 2004;85:1-8.
66. Haba E, Pinazo A, Jauregui O, Espuny MJ, Infante MR, Manresa A. Physicochemical characterization and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044. Biotechnol Bioeng. 2003;81:316-322.
67. Pamp SJ, Tolker-Nielsen T. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol. 2007;189:2531-2539.
68. Boles BR, Thoendel M, Singh PK. Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol. 2005;57:1210-1223.
69. Davey ME, Caiazza NC, O'Toole GA. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol. 2003;185:1027-1036.
70. Lequette Y, Greenberg EP. Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms. J Bacteriol. 2005;187:37-44.
71. Linker A, Jones RS. A new polysaccharide resembling alginic acid isolated from pseudomonads. J Biol Chem. 1966;241: 3845-3851.
72. Costerton JW, Cheng KJ, Geesey GG, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 1987;41:435-464.
73. Padgett PJ, Phibbs PV. Phosphomannomutase activity in wildtype and alginate-producing strains of Pseudomonas aeruginosa. Curr Microbiol. 1986;14:187-192.
74. Piggot NH, Sutherland IW, Jarman TR. Enzymes involved in the biosynthesis of alginate by Pseudomonas aeruginosa. Eur J Appl Microbiol Biotechnol. 1981;13:179-183.
75. Si-Correia I, Darzins A, Wang SK, Berry A, Chakrabarty AM. Alginate biosynthetic enzymes in mucoid and nonmucoid Pseudomonas aeruginosa: Overproduction of phosphomannose isomerase, phosphomannomutase, and GDP-mannose pyrophosphorylase by overexpression of the phosphomannose isomerase (pmi) gene. J Bacteriol. 1987;169:3224-3231.
76. Davies DG, Chakrabarty AM, Geesey GG. Exopolysaccharide production in biofilms: Substratum activation of alginate gene expression by Pseudomonas aeruginosa. Appl Environ Microbiol. 1993;59:1181-1186.
77. DeVault JD, Kimbara K, Chakrabarty AM. Pulmonary dehydration and infection in cystic fibrosis: Evidence that ethanol activates alginate gene expression and induction of mucoidy in Pseudomonas aeruginosa. Mol Microbiol. 1990;4:737-745.
78. DeVault JD, Berry A, Misra TK, Chakrabarty AM. Environmental sensory signals and microbial pathogenesis: Pseudomonas aeruginosa infection in cystic fibrosis. Bio/Technology. 1989;7:352-357.
79. Bayer AS, Eftekhar F, Tu J, Nast CC, Speert DP. Oxygendependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa. Infect Immun. 1990;58:1344-1349.
80. Zielinski NA, Maharaj R, Roychoudhury S, Danganan CE, Hendrickson W, Chakrabarty AM. Alginate synthesis in Pseudomonas aeruginosa: Environmental regulation of the algC promoter. J Bacteriol. 1992;174:7680-7688.